Literature DB >> 14522095

Stromal-cell derived factor-1 chemokine gene variant is associated with type 1 diabetes age at onset in Japanese population.

Akane Ide1, Eiji Kawasaki, Norio Abiru, Fuyan Sun, Tetsuya Fukushima, Ryoko Takahashi, Hironaga Kuwahara, Naruhiro Fujita, Atsushi Kita, Katsuya Oshima, Shigeo Uotani, Hironori Yamasaki, Yoshihiko Yamaguchi, Yumiko Kawabata, Tomomi Fujisawa, Hiroshi Ikegami, Katsumi Eguchi.   

Abstract

Stromal-cell derived factor-1 (SDF-1) is a powerful chemokine that upregulates T-cell migration and activation. The gene for SDF-1 is located near type 1 diabetes susceptibility locus IDDM10, suggesting a contribution by SDF-1 to the induction of diabetes. Recently the role of SDF-1 gene polymorphism in the clinical presentation of type 1 diabetes in French population has been reported. To test the putative involvement of SDF-1 gene polymorphism in predisposition to or clinical heterogeneity of type 1 diabetes in Japanese population, we conducted the case-control study. The SDF1-3'A variant (801 G to A in the 3'-untranslated region) was determined by the polymerase chain reaction-restriction fragment length polymorphism technique in 184 patients with abrupt-onset type 1 diabetes and 106 healthy control subjects. No significant difference in allele and genotype frequencies of SDF1-3'A variant was found between type 1 diabetic patients and healthy controls. However, the SDF1-3'A variant was strongly associated with early-onset diabetes in a recessive model (AA versus AG + GG, p = 0.017). The mean age-at-onset in patients carrying SDF1-3'AA genotype was significantly younger than that in patients with SDF1-3' AG or GG genotype (p = 0.028). The frequencies of SDF1-3' A variant were significantly increased in HLA-DR4/9 patients compared with non-DR4/9 patients (p = 0.008). These results suggest that the SDF-1 gene polymorphism is associated with the age-at-onset of type 1 diabetes in Japanese population.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14522095     DOI: 10.1016/s0198-8859(03)00176-9

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  12 in total

1.  The non-canonical NF-κB pathway is induced by cytokines in pancreatic beta cells and contributes to cell death and proinflammatory responses in vitro.

Authors:  Kira Meyerovich; Makiko Fukaya; Leticia F Terra; Fernanda Ortis; Decio L Eizirik; Alessandra K Cardozo
Journal:  Diabetologia       Date:  2015-12-03       Impact factor: 10.122

2.  Treg cells in pancreatic lymph nodes: the possible role in diabetogenesis and β cell regeneration in a T1D model.

Authors:  Benjamin K Nti; Janet L Markman; Suzanne Bertera; Alexis J Styche; Robert J Lakomy; Vladimir M Subbotin; Massimo Trucco; Tatiana D Zorina
Journal:  Cell Mol Immunol       Date:  2012-10-08       Impact factor: 11.530

3.  SDF1-3' G801A polymorphisms in Polish patients with systemic lupus erythematosus.

Authors:  Teresa Warchoł; Margarita Lianeri; Jan K Łacki; Paweł P Jagodziński
Journal:  Mol Biol Rep       Date:  2009-10-14       Impact factor: 2.316

4.  Stromal cell-derived factor-1 promotes survival of pancreatic beta cells by the stabilisation of beta-catenin and activation of transcription factor 7-like 2 (TCF7L2).

Authors:  Z Liu; J F Habener
Journal:  Diabetologia       Date:  2009-05-26       Impact factor: 10.122

Review 5.  The chemokine network. II. On how polymorphisms and alternative splicing increase the number of molecular species and configure intricate patterns of disease susceptibility.

Authors:  R Colobran; R Pujol-Borrell; M P Armengol; M Juan
Journal:  Clin Exp Immunol       Date:  2007-10       Impact factor: 4.330

6.  Elevated CXCL12 expression in the bone marrow of NOD mice is associated with altered T cell and stem cell trafficking and diabetes development.

Authors:  Qibin Leng; Yuchun Nie; Yongrui Zou; Jianzhu Chen
Journal:  BMC Immunol       Date:  2008-09-15       Impact factor: 3.615

7.  SDF1 gene variation is associated with circulating SDF1alpha level and endothelial progenitor cell number: the Bruneck Study.

Authors:  Qingzhong Xiao; Shu Ye; Friedrich Oberhollenzer; Agnes Mayr; Marjan Jahangiri; Johann Willeit; Stefan Kiechl; Qingbo Xu
Journal:  PLoS One       Date:  2008-12-30       Impact factor: 3.240

8.  Serum concentration of angiogenic (CXCL1, CXCL12) and angiostasis (CXCL9, CXCL10) CXC chemokines are differentially altered in normal and gestational diabetes mellitus associated pregnancies.

Authors:  Shokoofeh Darakhshan; Abbas Fatehi; Gholamhossein Hassanshahi; Soodabeh Mahmoodi; Monireh Seyed Hashemi; Mojgan Noroozi Karimabad
Journal:  J Diabetes Metab Disord       Date:  2019-07-29

9.  PARP-1 and YY1 are important novel regulators of CXCL12 gene transcription in rat pancreatic beta cells.

Authors:  Jelena Marković; Nevena Grdović; Svetlana Dinić; Teodora Karan-Djurašević; Aleksandra Uskoković; Jelena Arambašić; Mirjana Mihailović; Sonja Pavlović; Goran Poznanović; Melita Vidaković
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

10.  Sequencing and association analysis of the type 1 diabetes-linked region on chromosome 10p12-q11.

Authors:  Sergey Nejentsev; Luc J Smink; Deborah Smyth; Rebecca Bailey; Christopher E Lowe; Felicity Payne; Jennifer Masters; Lisa Godfrey; Alex Lam; Oliver Burren; Helen Stevens; Sarah Nutland; Neil M Walker; Anne Smith; Rebecca Twells; Bryan J Barratt; Charmain Wright; Lisa French; Yuan Chen; Panagiotis Deloukas; Jane Rogers; Ian Dunham; John A Todd
Journal:  BMC Genet       Date:  2007-05-17       Impact factor: 2.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.